Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve the un-audited standalone and ....
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare has informed the stock exchanges that its Board of Directors will meet on Thursday, 13th November 2025 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025 (Q2 and H1 FY26). The Board will also review the Limited Review Reports of the auditors on these results. The company's trading window for designated persons has been closed since 1st October 2025 and will reopen 48 hours after the results are published. No actual financial figures have been disclosed in this filing.
This is a routine procedural intimation with no direct impact on shareholders. Investors should watch for the actual Q2/H1 results announcement on or after 13th November for any meaningful business or stock price implications.